Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
about
Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: Clinical significance and biologic implicationsProgression of cutaneous melanoma: implications for treatmentWeighing the value of completion nodal dissection for melanoma.Lower tumour burden and better overall survival in melanoma patients with regional lymph node metastases and negative preoperative ultrasound.Data set for pathology reporting of cutaneous invasive melanoma: recommendations from the international collaboration on cancer reporting (ICCR).Multimarker reverse transcriptase-polymerase chain reaction assay in lymphatic drainage and sentinel node tumor burden.Prognosis in patients with sentinel node-positive melanoma without immediate completion lymph node dissection.Sentinel lymph node biopsy in melanoma: our 8-year clinical experience in a single French institute (2002-2009)Biopathologic features and clinical significance of micrometatasis in the lymph node of early gastric cancerControversies in the diagnosis and treatment of early cutaneous melanoma.Preoperative ultrasound is not useful for identifying nodal metastasis in melanoma patients undergoing sentinel node biopsy: preoperative ultrasound in clinically node-negative melanomaThe long-term results and prognostic significance of cutaneous melanoma surgery using sentinel node biopsy with triple techniqueLymph Node Micrometastases and In-Transit Metastases from Melanoma: In Vivo Detection with Multispectral Optoacoustic Imaging in a Mouse Model.Future perspectives in melanoma research : Meeting report from the "Melanoma Bridge". Napoli, December 1st-4th 2015.Treatment and prognostic significance of positive interval sentinel nodes in patients with primary cutaneous melanoma.The impact of primary melanoma thickness and microscopic tumor burden in sentinel lymph nodes on melanoma patient survival.New developments in melanoma: utility of ultrasound imaging (initial staging, follow-up and pre-SLNB).Advances in sentinel lymph node mapping for patients with melanoma.Surgical treatment of melanoma patients with early sentinel node involvement.Melanoma metastasis: new concepts and evolving paradigms.Is the non-sentinel lymph node compartment the next site for melanoma progression from the sentinel lymph node compartment in the regional nodal basin?Cancer Education in Poland: Current Status and Suggestions for ImprovementMulti-slice SPECT/CT vs. lymphoscintigraphy and intraoperative gamma ray probe for sentinel node mapping in HNSCC.Prolonged Survival in Stage III Melanoma with Ipilimumab Adjuvant TherapyInflammation and tumor microenvironment in lymph node metastasis.Detailed pathological examination of completion node dissection specimens and outcome in melanoma patients with minimal (<0.1 mm) sentinel lymph node metastases.Decoding melanoma metastasisPotential cost-effectiveness of US-guided FNAC in melanoma patients as a primary procedure and in follow-up.Survival and the sentinel lymph node in melanoma.Outcome of clinical stage III melanoma patients with FDG-PET and whole-body CT added to the diagnostic workup.Sentinel lymph node biopsy in patients with Merkel cell carcinoma: an emerging role and the Westmead hospital experience.Observation after a positive sentinel lymph node biopsy in patients with melanoma.Sentinel node dissection delays recurrence and prolongs melanoma-related survival: an analysis of 673 patients from a single center with long-term follow-up.Prognostic role of sentinel node biopsy in patients with thick melanoma: a meta-analysis.Identification, clinical significance, and management of very small melanoma metastases in sentinel lymph nodes.EANM practice guidelines for lymphoscintigraphy and sentinel lymph node biopsy in melanoma.Sentinel node metastasis mitotic rate (SN-MMR) as a prognostic indicator of rapidly progressing disease in patients with sentinel node-positive melanomas.Melanoma staging: Evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual.Frozen section analysis of SLNs in trunk and extremity melanoma has a high false negative rate but can spare some patients a second operation.Completion lymphadenectomy for sentinel node positive cutaneous head & neck melanoma.
P2860
Q26996059-C2E152FD-27C6-42A7-A3B7-F43B5D0FE056Q27001734-F547E5B2-4507-4287-BE1A-0D2BB848626BQ30248851-3AA9AC56-87B6-4908-9342-C41F55C34C11Q30558101-BA67759F-BDE1-44F3-92F2-BE8A7230553EQ30669529-3B8D6A84-A065-4655-9EA1-CD8F7E5A8D19Q34372934-DD3DAB4F-019C-4B68-A31D-C125BED699C7Q34409481-9DFFA1C6-6312-4551-8CEE-633383277406Q34507667-9DC23CDA-FEAF-464C-8AC0-E0B836935DA3Q34932726-AB80FB38-1646-4190-B688-DF1A462CC559Q35349822-8567988F-1595-49B3-B334-78389E9120E4Q35856660-4CD7F7A2-7163-4813-8E93-7BABDB69F26CQ36155641-BDDC9458-2D60-4D5D-8775-5E4C3C5CA303Q37090076-9A5085CA-6D49-4CD0-B968-3E33D7D8FFF3Q37417271-A470826C-DAC2-4E2B-B075-CB0CD27ED06AQ37931078-B12D6AF9-B431-4DF4-90AA-EA7C389CA615Q37944487-5D733CF2-B1A7-421A-8357-83F7AD4EFE2AQ37952237-6CFCBE35-73AD-418B-A349-BE213973E7DAQ37984125-D5070F55-18A0-4A28-B8CA-8FEC5585C6ABQ38027415-710CF008-2B4C-4B2B-81A6-3711AA721035Q38111220-90728156-2FD3-4F32-8C70-03C6851EDDF0Q38683103-A6843057-41A2-4217-AE93-94F468B9D290Q38809573-84B7F911-A943-4F2D-A636-790AE7323202Q39193367-80AA59C4-8164-4142-B752-13961E61A060Q39311439-1E9C4533-228D-4BDB-A350-454DE3A9D300Q39799151-85A9164B-C4E8-462C-A8B0-54A10F3D6D2EQ40922293-2ACAE0AE-301C-4D49-9D10-84B154270F37Q42575715-E6958DC3-A4D0-4EF8-8353-9D93D192A43BQ42922868-E82B4F01-5344-4B83-BE87-4BA35B86923DQ42938255-2CA9D7E2-5B82-48FA-983D-1F2BA318990DQ43705084-E569C7CC-A1D3-4214-A61E-6320CF2A96E1Q43751746-0566FDEC-93B6-4203-BD2D-F6B0D6CC70F6Q44711648-F33DF854-FE19-4999-B39B-8CFDF09AF91CQ44756636-160937DC-A8F2-41AB-B0DB-51B1B1360FCCQ44808389-07E38B3B-94D2-4FF6-8CB6-1C7E86401525Q46300663-E1710FAE-B885-45D0-A1D7-A86C1CEB1B87Q46844304-D3003396-8295-40EE-A2CF-F4A13B529DBFQ47611324-8760BB2C-B4E0-467E-9C8C-B61A8A433DA1Q47803820-D60DD64E-361F-4273-9F48-15DE61C87048Q52980009-39F45DCA-07FA-4F02-8ECC-D4F9E1B41585Q55248566-70274F58-8076-4364-B6B1-B7246D09DB34
P2860
Sentinel node tumor burden according to the Rotterdam criteria is the most important prognostic factor for survival in melanoma patients: a multicenter study in 388 patients with positive sentinel nodes.
description
2008 nî lūn-bûn
@nan
2008 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@ast
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@en
type
label
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@ast
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@en
prefLabel
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@ast
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@en
P2093
P1433
P1476
Sentinel node tumor burden acc ...... with positive sentinel nodes.
@en
P2093
Alexander C J van Akkooi
Alexander M M Eggermont
Christiane Voit
Cornelis Verhoef
Gregor Schäfer-Hesterberg
Johannes H W de Wilt
Wanda Michej
Zbigniew I Nowecki
P304
P356
10.1097/SLA.0B013E31818FEFE0
P407
P577
2008-12-01T00:00:00Z